Assessment of Subclinical Deterioration of Right Ventricular Function by Three-Dimensional Speckle Tracking Echocardiography in Breast Cancer Patients Undergoing Anthracycline-Based Chemotherapy

References

• Siegel R, Naishadm D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2019;69:7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–1084. doi:10.1056/NEJM200004133421502
   PubMed Web of Science ®Google Scholar
• Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2768–2801. doi:10.1093/eurheartj/ehw211
   PubMed Web of Science ®Google Scholar
• Lorenzini C, Lamberti C, Aquilina M, et al. Reliability of left ventricular ejection fraction from three-dimensional echocardiography for cardiotoxicity onset detection in patients with breast cancer. J Am Soc Echocardiogr. 2017;30:1103–1110. doi:10.1016/j.echo.2017.06.025
   PubMed Web of Science ®Google Scholar
• Narayan HK, Finkelman B, French B, et al. Detailed echocardiographic phenotyping in breast cancer patients: associations with ejection fraction decline, recovery, and heart failure symptoms over 3 years of follow-up. Circulation. 2017;135:1397–1412. doi:10.1161/CIRCULATIONAHA.116.023463
   PubMed Web of Science ®Google Scholar
• Zhang KW, Finkelman BS, Gulati G, et al. Abnormalities in 3-dimensional left ventricular mechanics with anthracycline chemotherapy are associated with systolic and diastolic dysfunction. JACC Cardiovasc Imaging. 2018;11:1059–1068. doi:10.1016/j.jcmg.2018.01.015
   PubMed Web of Science ®Google Scholar
• Nagata Y, Wu VC, Kado Y, et al. Prognostic value of right ventricular ejection fraction assessed by transthoracic 3D echocardiography. Circ Cardiovasc Imaging. 2017;10:e005384. doi:10.1161/CIRCIMAGING.116.005384
   PubMed Web of Science ®Google Scholar
• Addetia K, Maffessanti F, Muraru D, et al. Morphologic analysis of the normal right ventricle using three-dimensional echocardiography-derived curvature indices. J Am Soc Echocardiogr. 2018;31:614–623. doi:10.1016/j.echo.2017.12.009
   PubMed Web of Science ®Google Scholar
• Leibundgut G, Rohner A, Grize L, et al. Dynamic assessment of right ventricular volumes and function by real-time three-dimensional echocardiography: a comparison study with magnetic resonance imaging in 100 adult patients. J Am Soc Echocardiogr. 2010;23:116–126. doi:10.1016/j.echo.2009.11.016
   PubMed Web of Science ®Google Scholar
• Muraru D, Spadotto V, Cecchetto A, et al. New speckle-tracking algorithm for right ventricular volume analysis from three-dimensional echocardiographic data sets: validation with cardiac magnetic resonance and comparison with the previous analysis tool. Eur Heart J Cardiovasc Imaging. 2016;17:1279–1289. doi:10.1093/ehjci/jev309
   PubMed Web of Science ®Google Scholar
• Ishizu T, Seo Y, Atsumi A, et al. Global and regional right ventricular function assessed by novel three-dimensional speckle-tracking echocardiography. J Am Soc Echocardiogr. 2017;30:1203–1213. doi:10.1016/j.echo.2017.08.007
   PubMed Web of Science ®Google Scholar
• Song FY, Shi J, Guo Y, et al. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy. Int J Cardiovasc Imaging. 2017;33:857–868. doi:10.1007/s10554-017-1082-6
   PubMed Web of Science ®Google Scholar
• Keramida K, Farmakis D, Bingcang J, et al. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients. Eur J Heart. 2019;21:529–535. doi:10.1002/ejhf.1385
   Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39 e14. doi:10.1016/j.echo.2014.10.003
   PubMed Web of Science ®Google Scholar
• Jacobse JN, Steggink LC, Sonke GS, et al. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40–50 years. Eur J Heart Fail. 2020;22:338–346. doi:10.1002/ejhf.1610
   PubMed Web of Science ®Google Scholar
• Bosch L, Lam CSP, Gong L, et al. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction. Eur J Heart Fail. 2017;19:1664–1671. doi:10.1002/ejhf.873
   PubMed Web of Science ®Google Scholar
• Muraru D, Badano LP, Nagata Y, et al. Development and prognostic validation of partition values to grade right ventricular dysfunction severity using 3D echocardiography. Eur Heart J Cardiovasc Imaging. 2020;21:10–21. doi:10.1093/ehjci/jez233
   PubMed Web of Science ®Google Scholar
• El-Sherbeny WS, Sabry NM, Sharbay RM. Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy. J Echocardiogr. 2019;17:76–83. doi:10.1007/s12574-018-0394-4
   PubMed Web of Science ®Google Scholar
• Chen L, Huang J, Wu W, Ta S, Xie X. The impact of right ventricular function on prognosis in patients with stage III non small cell lung cancer after concurrent chemoradiotherapy. Int J Cardiovasc Imaging. 2019;35:1009–1017. doi:10.1007/s10554-019-01590-0
   PubMed Web of Science ®Google Scholar
• Calleja A, Poulin F, Khorolsky C. et al. Right ventricular dysfunction in patients experiencing cardiotoxicity during breast cancer therapy. J Oncol. 2015;609194. doi:10.1155/2015/609194
   PubMed Web of Science ®Google Scholar
• Cherata DA, Donoiu I, Diaconu R, et al. Longitudinal strain analysis allows the identification of subclinical deterioration of right ventricular function in patients with cancer therapy-related left ventricular dysfunction. Discoveries (Craiova). 2019;7:e94. doi:10.15190/d.2019.7
   PubMedGoogle Scholar
• Chang WT, Shih JY, Feng YH, et al. The early predictive value of right ventricular strain in epirubicin-induced cardiotoxicity in patients with breast cancer. Acta Cardiol Sin. 2016;32:550–559. doi:10.6515/acs20151023a
   PubMed Web of Science ®Google Scholar
• Abdar Esfahani M, Mokarian F, Karimipanah M. Alterations in the echocardiographic variables of the right ventricle in asymptomatic patients with breast cancer during anthracycline chemotherapy. Postgrad Med J. 2017;93:271–274. doi:10.1136/postgradmedj-2016-134286
   PubMed Web of Science ®Google Scholar
• Husain N, Gokhale J, Nicholson L, Cheatham JP, Holzer RJ, Cua CL. Noninvasive estimation of ventricular filling pressures in patients with single right ventricles. J Am Soc Echocardiogr. 2013;26:1330–1336. doi:10.1016/j.echo.2013.08.002
   PubMed Web of Science ®Google Scholar
• Ky B, Putt M, Sawaya H, et al. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol. 2014;63:809–816. doi:10.1016/j.jacc.2013.10.061
   PubMed Web of Science ®Google Scholar
• Jones M, O’Gorman P, Kelly C, Mahon N, Fitzgibbon MC. High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury. Ann Clin Biochem. 2017;54:149–157. doi:10.1177/0004563216650464
   PubMed Web of Science ®Google Scholar
• Simoes R, Silva LM, Cruz A, et al. Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: a narrative review. Biomed Pharmacother. 2018;107:989–996. doi:10.1016/j.biopha.2018.08.035
   PubMed Web of Science ®Google Scholar